NFE2L2 and chronic obstructive pulmonary disease: In a longitudinal observational study, the GSH levels in plasma and the expression levels of NRF2-related genes in peripheral blood mononuclear cells appeared to serve as indicative biomarkers for the progression of disease in COPD patients [61,62].